Neonatal-onset maculopapular cutaneous mastocytosis presenting with pigmented plaques in an infant

Authors

  • Alexa M. Flores-Leonel Division of Dermatology, Hospital General Dr. Manuel Gea González, Mexico City, Mexico https://orcid.org/0009-0006-9446-1239
  • Itzel G. Elizalde-Jiménez Division of Dermatology, Hospital General Dr. Manuel Gea González, Mexico City, Mexico
  • Carlos D. Sánchez-Cardenas Department of Dermatopathology, Hospital General Dr. Manuel Gea González, Mexico City, Mexico
  • Ana L. Ramírez-Terán Division of Dermatology, Hospital General Dr. Manuel Gea González, Mexico City, Mexico https://orcid.org/0000-0001-8449-4041

DOI:

https://doi.org/10.18203/2349-3291.ijcp20262977

Keywords:

Maculopapular cutaneous mastocytosis, Urticaria pigmentosa, Pigmented plaques

Abstract

Cutaneous mastocytosis is a clonal disorder characterized by abnormal accumulation of mast cells in the skin. Maculopapular cutaneous mastocytosis (urticaria pigmentosa) is the most common form in children and usually presents within the first two years of life. Neonatal onset and blistering may complicate recognition and mimic other pigmentary dermatoses. We report a 10-month-old male with six well-defined brown plaques measuring 2–3 cm, two with central scars. A blister was noted at birth on the knee, followed by progressive lesion development. Physical examination revealed no lymphadenopathy or visceromegaly. Histopathology demonstrated dense dermal mast cell infiltration with metachromatic granules on Giemsa staining, confirming maculopapular cutaneous mastocytosis. The patient was treated with oral ketotifen with stable disease at six-month follow-up. Early recognition is essential to ensure appropriate counseling, monitoring, and avoidance of unnecessary investigations.

References

Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka HM, et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140(11):1200-28.

Valent P, Akin C, Metcalfe DD. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 2017;129:1420-7.

Swarnkar B, Sarkar R. Childhood cutaneous mastocytosis: revisited. Indian J Dermatol. 2023;68(1):121.

Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J. 2005;7(5):320-2.

Méni C, Bruneau J, Georgin-Lavialle S, Le Saché de Peufeilhoux L, Damaj G, Hadj-Rabia S, et al. Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol. 2015;172(3):642-51.

Fokoloros C, Xepapadaki P, Papadavid E, Katoulis A, Pappa V, Papageorgiou S, et al. Mastocytosis in the Skin: Disease Heterogeneity among Children and Adults. Acta Derm Venereol. 2023;103:adv00845.

Brockow K, Bent RK, Schneider S, Spies S, Kranen K, Hindelang B, et al. Challenges in the diagnosis of cutaneous mastocytosis. Diagnostics (Basel). 2024;14(2):161.

Eichenfield LF, Honig PJ. Blistering disorders in childhood. Pediatr Clin N Am. 1991;38:959-76.

Slapnicar CA, Smeenk CS, Hicks LK, Petrucci J, Vadas P, Trinkaus M. A retrospective case series describing the efficacy of ketotifen in systemic mastocytosis. Blood. 2018;132(Suppl 1):5474.

Heinze A, Kuemmet TJ, Chiu YE, Galbraith SS. Longitudinal Study of Pediatric Urticaria Pigmentosa. Pediatr Dermatol. 2017;34:144-9.

Downloads

Published

2026-08-26

How to Cite

Flores-Leonel, A. M., Elizalde-Jiménez, I. G., Sánchez-Cardenas, C. D., & Ramírez-Terán , A. L. (2026). Neonatal-onset maculopapular cutaneous mastocytosis presenting with pigmented plaques in an infant. International Journal of Contemporary Pediatrics, 13(9), 1838–1840. https://doi.org/10.18203/2349-3291.ijcp20262977

Issue

Section

Case Reports